Table 1 Total number (top) and percentage (bottom) of patients with single site metastasis to bone, liver, lung, or brain, segmented by breast cancer subtype
From: Premetastatic niche mechanics and organotropism in breast cancer
Single Site Metastasis | ||||||||
|---|---|---|---|---|---|---|---|---|
Bone | Liver | Lung | Brain | |||||
Luminal A HR + /HER2- | 2144 | 178 | 194 | 69 | 335 | 85 | 27 | 6 |
79.4% | 52.7% | 7.2% | 20.4% | 12.4% | 25.1% | 1.0% | 1.8% | |
Luminal B HR + /HER2+ | 304 | 452 | 113 | 265 | 63 | 299 | 7 | 32 |
62.4% | 43.1% | 23.2% | 25.3% | 12.9% | 28.5% | 1.4% | 3.1% | |
HR-/HER2+ | 112 | 150 | 131 | 148 | 80 | 189 | 14 | 20 |
33.2% | 29.6% | 38.9% | 29.2% | 23.7% | 37.3% | 4.2% | 3.9% | |
Triple-Negative | 243 | 155 | 106 | 87 | 257 | 156 | 35 | 23 |
37.9% | 36.8% | 16.5% | 20.7% | 40.1% | 37.1% | 5.5% | 5.5% | |
